Thank you for joining us and sharing news out about #Tandem24! Questions regarding media registration status, images or conference contributors can be directed to Jenn Kasowicz, ASTCT Director of Marketing and Communications, at firstname.lastname@example.org. Press may register to cover the event in-person or remotely.
Looking to get in touch with the Scientific Organizing Committee Co-Chairs or any of our Track Chairs? Please reach out to Jenn Kasowicz at email@example.com to set up an interview.
The American Society for Transplantation and Cellular Therapy (ASTCT®) is an international professional membership association of more than 3,900 physicians, investigators, and other health care professionals from more than 50 countries. Its mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
The CIBMTR®(Center for International Blood and Marrow Transplant Research®) is a research collaboration between NMDP℠ and the Medical College of Wisconsin (MCW). The CIBMTR collaborates with the global scientific community to advance hematopoietic cell transplantation (HCT) and cellular therapy worldwide to increase survival and enrich quality of life for patients. The CIBMTR facilitates critical observational and interventional research through scientific and statistical expertise, a large network of transplant centers, and a unique and extensive clinical outcomes database.
The 2024 Tandem Meetings will take place February 21-24, 2024, in San Antonio, Texas, and will feature in-person and virtual programming, so everyone can experience the premier event in the evolving hematopoietic cell transplantation and cellular therapy field. The event grants access to the latest scientific updates, new technologies, and innovative products. Leading experts from around the world will convene to share key insights to help healthcare professionals and researchers save and improve the lives of patients with blood-related disorders.